Monophasic fibrous and poorly differentiated synovial sarcoma - Immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases

被引:149
|
作者
Pelmus, M
Guillou, L
Hostein, I
Sierankowski, G
Lussan, C
Coindre, JM
机构
[1] Inst Bergonie, Pathol Lab, F-33076 Bordeaux, France
[2] Univ Bordeaux 2, F-33076 Bordeaux, France
[3] Univ Lausanne, Inst Pathol, Lausanne, Switzerland
关键词
synovial; sarcoma; t(X; 8); immunohistochemistry;
D O I
10.1097/00000478-200211000-00005
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Diagnosing monophasic fibrous and poorly differentiated synovial sarcoma (SS) on morphology alone is often a source of problems for pathologists. SS bear the t(X;18)(p11.2,q11.2) translocation, which proved to be specific for this tumor type and is currently considered one of the most reliable diagnostic criteria. To evaluate the sensitivity of immunohistochemical techniques in diagnosing monophasic fibrous SS (MFSS) and poorly differentiated SS (PDSS), we examined 60 t(X;18)(SYT-SSX)-positive cases (47 MFSS and 13 PDSS) for cytokeratin AE1/AE3, cytokeratin KL1, epithelial membrane antigen, E-cadherin, CD34, S-100 protein, alpha-smooth muscle actin, desmin, h-caldesmon, CD99, bcl2, and C-kit (CD 117) antibodies. Of the four epithelial markers tested, epithelial membrane antigen proved to be the most sensitive, reacting with 100% of MFSS and 92% of PDSS, followed by cytokeratin AE1/AE3 (70% of MFSS, 46% of PDSS), cytokeratin KL1 (49% of MFSS, 38% of PDSS), and E-cadherin (47% of MFSS, 54% of PDSS). A staining for cytokeratin AE1/AE3 and/or E-cadherin was observed in 79% of MFSS and 69% of PDSS, and a staining for cytokeratin KL1 and/or E-cadherin was observed in 74% of MFSS and 62% of PDSS. S-100 protein was positive in 38% of MFSS and 23% of PDSS, and alpha-smooth muscle actin in 21% of MFSS and 8% of PDSS. Tumor cells were rarely positive for CD34 (6% of MFSS, 0% of PDSS) and desmin (2% of MFSS, 0% of PDSS). Most SS were strongly positive for bcl-2 (91% of MFSS, 92% of PDSS) and CD99 (91% of MFSS, 100% of PDSS). A weak and focal cytoplasmic reactivity for CD 117 was observed in 11% of MFSS (only one case had a strong immunoreactivity) and 8% of PDSS. Staining with h-caldesmon was consistently negative. In conclusion, in keeping with literature data, our results show that reactivity for epithelial membrane antigen, cytokeratin AE1/AE3, and E-cadherin, in combination with CD34 negativity, are the most useful and sensitive markers for diagnosing monophasic fibrous and poorly differentiated t(X;18)-positive SS. They also support the fact that about one third of MFSS and one fourth of PDSS are positive for S-100 protein, a finding of diagnostic relevance when considering their distinction from other spindle to round cell sarcomas, especially malignant peripheral nerve sheath tumors.
引用
收藏
页码:1434 / 1440
页数:7
相关论文
共 40 条
  • [1] Primary monophasic synovial sarcoma of the pleura - Five cases confirmed by the presence of SYT-SSX fusion transcript
    Aubry, MC
    Bridge, JA
    Wickert, R
    Tazelaar, HD
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (06) : 776 - 781
  • [2] Primary cervical tracheal monophasic synovial sarcoma confirmed by SYT-SSX gene rearrangement
    Corrales, C. E.
    Berry, G.
    Damrose, E. J.
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2011, 125 (06): : 651 - 654
  • [3] Poorly differentiated primary pulmonary synovial sarcoma confirmed by detection of the SYT-SSX fusion gene: a case report with a literature review
    Zhao, Zhengkai
    Yu, Jing
    Wu, Jianlin
    Zhu, Ruiping
    Cheng, Shaoling
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (04): : 7250 - 7255
  • [4] Cryptic t(X;18), ins(6;18), and SYT-SSX2 gene fusion in a case of intraneural monophasic synovial sarcoma
    Lestou, VS
    O'Connell, JX
    Robichaud, M
    Salski, C
    Mathers, J
    Maguire, J
    Chudoba, I
    Sorensen, PHB
    Lam, W
    Horsman, DE
    CANCER GENETICS AND CYTOGENETICS, 2002, 138 (02) : 153 - 156
  • [5] The SYT-SSX fusion protein down-regulates the cell proliferation regulator COM1 in t(x;18) synovial sarcoma
    Ishida, Michiko
    Miyamoto, Mamiko
    Naitoh, Sayu
    Tatsuda, Daisuke
    Hasegawa, Tadashi
    Nemoto, Takeshi
    Yokozeki, Hiroo
    Nishioka, Kiyoshi
    Matsukage, Akio
    Ohki, Misao
    Ohta, Tsutornu
    MOLECULAR AND CELLULAR BIOLOGY, 2007, 27 (04) : 1348 - 1355
  • [6] Primary synovial sarcoma of the lung: report of two cases confirmed by molecular detection of SYT-SSX fusion gene transcripts
    Hisaoka, M
    Hashimoto, H
    Iwamasa, T
    Ishikawa, K
    Aoki, T
    HISTOPATHOLOGY, 1999, 34 (03) : 205 - 210
  • [7] Detection of the SYT-SSX chimeric RNA of synovial sarcoma in paraffin-embedded tissue and its application in problematic cases
    Argani, P
    Zakowski, MF
    Klimstra, DS
    Rosai, J
    Ladanyi, M
    MODERN PATHOLOGY, 1998, 11 (01) : 65 - 71
  • [8] A poorly differentiated synovial sarcoma (SYT/SSX1) expresses neuroectodermal markers - A xenografts and in vitro culture study
    Rosa, N
    Samuel, N
    Lopez-Guerrero
    Antonio, J
    Carmen, C
    Antonio, P
    Antonio, LB
    DIAGNOSTIC MOLECULAR PATHOLOGY, 2004, 13 (01) : 52 - 59
  • [9] Simultaneous analysis of t(X;18) by FISH- und SYT/SSX-RT-PCR in synovial sarcoma
    Katenkamp, K
    Richter, P
    Slatosch, T
    Katenkamp, D
    Berndt, A
    PATHOLOGE, 2005, 26 (02): : 111 - 116
  • [10] Primary poorly differentiated monophasic synovial sarcoma of the lung. A case report with immunohistochemical and genetic studies
    Mikami, Y
    Nakajima, M
    Hashimoto, H
    Kuwabara, K
    Sasao, Y
    Manabe, T
    PATHOLOGY RESEARCH AND PRACTICE, 2003, 199 (12) : 827 - 833